Logo

Oxford Molecular Debuts New Version of Assay and Screening Data System

Feb 25, 2000
Premium

H

UNT VALLEY, Md.--Oxford Molecular Group has launched OMMM 2.0, designed for use by biologists, pharmacologists, and research managers in the drug discovery screening environment. OMMM, the desktop-component of Oxford’s Oracle-based system for enterprisewide and smaller screening operations and workgroups, is a flexible tool that can be configured to meet specific lab needs, said the company. The new release has enhanced tools for data analysis and features to enable easier use and greater levels of automation and customization.

Filed under

Informatics
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.